CATALOGO DEI PRODOTTI DELLA RICERCA

Maggino, Laura
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.521
EU - Europa 3.553
AS - Asia 2.692
SA - Sud America 367
Continente sconosciuto - Info sul continente non disponibili 144
AF - Africa 90
OC - Oceania 9
Totale 11.376
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.338
RU - Federazione Russa 1.513
SG - Singapore 1.068
CN - Cina 797
GB - Regno Unito 519
IT - Italia 418
BR - Brasile 266
DE - Germania 236
HK - Hong Kong 236
VN - Vietnam 222
FR - Francia 209
IE - Irlanda 193
SE - Svezia 169
CA - Canada 84
KR - Corea 83
FI - Finlandia 82
BD - Bangladesh 65
IN - India 50
UA - Ucraina 48
JP - Giappone 45
AR - Argentina 36
NL - Olanda 36
MX - Messico 25
PL - Polonia 21
TR - Turchia 21
ID - Indonesia 19
NG - Nigeria 19
ES - Italia 16
BE - Belgio 15
CO - Colombia 14
CR - Costa Rica 14
EC - Ecuador 14
IQ - Iraq 12
JM - Giamaica 12
ZA - Sudafrica 12
DZ - Algeria 11
HN - Honduras 11
TG - Togo 11
AT - Austria 9
SA - Arabia Saudita 9
AU - Australia 8
BJ - Benin 8
CL - Cile 8
PE - Perù 8
PY - Paraguay 8
UZ - Uzbekistan 8
VE - Venezuela 8
CZ - Repubblica Ceca 7
EE - Estonia 7
GT - Guatemala 7
MA - Marocco 7
PH - Filippine 7
AL - Albania 6
KE - Kenya 6
NI - Nicaragua 6
SV - El Salvador 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
CW - ???statistics.table.value.countryCode.CW??? 5
GR - Grecia 5
IL - Israele 5
JO - Giordania 5
PK - Pakistan 5
PR - Porto Rico 5
RO - Romania 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
HU - Ungheria 4
KG - Kirghizistan 4
MY - Malesia 4
NO - Norvegia 4
PT - Portogallo 4
TN - Tunisia 4
DK - Danimarca 3
EG - Egitto 3
EU - Europa 3
LT - Lituania 3
LV - Lettonia 3
UG - Uganda 3
BG - Bulgaria 2
GP - Guadalupe 2
IR - Iran 2
KZ - Kazakistan 2
NP - Nepal 2
OM - Oman 2
PS - Palestinian Territory 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
BZ - Belize 1
DM - Dominica 1
DO - Repubblica Dominicana 1
Totale 11.220
Salva come PNG Salva come JPEG
Città #
Ashburn 728
Singapore 538
Moscow 515
Southend 438
San Jose 433
Chandler 418
Dallas 363
Hong Kong 227
Council Bluffs 195
Dublin 186
Verona 183
Beijing 179
Jacksonville 153
The Dalles 143
Woodbridge 111
Ho Chi Minh City 79
Los Angeles 76
Munich 73
Houston 67
Lawrence 66
New York 65
Princeton 65
Jinan 55
Hanoi 53
Santa Clara 53
Redmond 49
Wilmington 48
Nanjing 43
Helsinki 40
Shenyang 39
Tokyo 36
São Paulo 35
Redondo Beach 34
Buffalo 31
Columbus 30
Orem 30
Tianjin 29
Milan 27
Ann Arbor 24
Haikou 24
Hangzhou 23
Redwood City 23
Frankfurt am Main 22
Montreal 22
Seattle 22
Atlanta 20
Changsha 19
Hebei 19
London 19
Ningbo 19
Sindelfingen 19
Washington 19
Brooklyn 18
Chicago 18
Nanchang 18
Toronto 18
Turku 18
Abuja 17
Denver 17
Falkenstein 16
Rio de Janeiro 16
Warsaw 16
Amsterdam 15
Brussels 15
Chennai 14
Nuremberg 13
San Francisco 13
San José 13
Zhengzhou 13
Fairfield 12
Lomé 11
Mexico City 11
Norwalk 11
Taiyuan 11
Taizhou 11
Fuzhou 10
Haiphong 10
Mumbai 10
Paris 10
Phoenix 10
Belo Horizonte 9
Genoa 9
Jakarta 9
Johannesburg 9
Lancaster 9
Lappeenranta 9
Philadelphia 9
Stockholm 9
Cotonou 8
Falls Church 8
Miami 8
Rome 8
Tashkent 8
Baghdad 7
Guangzhou 7
Istanbul 7
Manchester 7
Ottawa 7
Poplar 7
Ankara 6
Totale 6.772
Salva come PNG Salva come JPEG
Nome #
Unraveling the role of lymph node metastasis in PDAC and dCCA progression 401
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma 241
Downstaging in Stage IV Pancreatic Cancer: A New Population Eligible for Surgery? 232
Decoding Grade B Pancreatic Fistula: A Clinical and Economical Analysis and Subclassification Proposal 228
Pancreaticoduodenectomy in patients ≥ 75 years of age: Are there any differences with other age ranges in oncological and surgical outcomes? Results from a tertiary referral center 227
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 210
A Pretreatment Prognostic Score to Stratify Survival in Pancreatic Cancer 202
A dynamic analysis of empirical survival outcomes after pancreatectomy for pancreatic ductal adenocarcinoma 197
An unforeseeable adverse event during ERCP 190
Results of a surveillance protocol for pancreatic BD-IPMNs 189
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 188
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 187
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 187
International Validation of the Eighth Edition of the American Joint Committee on Cancer (AJCC) TNM Staging System in Patients With Resected Pancreatic Cancer 184
Analysis and proceeding to full publication of abstracts presented at the Pancreas Club annual meeting 184
Distal pancreatectomy associated with multivisceral resection: results from a single centre experience 183
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM 178
Risk Factors and Mitigation Strategies for Pancreatic Fistula After Distal Pancreatectomy: Analysis of 2026 Resections From the International, Multi-institutional Distal Pancreatectomy Study Group 173
ASO Visual Abstract: Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective Lymphadenectomy Protocol 169
Does the surgical waiting list affect pathological and survival outcome in resectable pancreatic ductal adenocarcinoma? 167
Core Set of Patient-reported Outcomes in Pancreatic Cancer (COPRAC) An International Delphi Study Among Patients and Health Care Providers 167
Neoadjuvant Therapy Versus Upfront Resection for Pancreatic Cancer: The Actual Spectrum and Clinical Burden of Postoperative Complications 165
ASO Author Reflections: Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma 161
Assessment of a complication risk score and study of complication profile in laparoscopic distal pancreatectomy 160
Pancreatic Adenocarcinoma 159
Assessing the influence of experience in pancreatic surgery: a risk-adjusted analysis using the American College of Surgeons NSQIP database 159
Long-term Outcomes After Surgical Resection of Pancreatic Metastases from Renal Clear-Cell Carcinoma 159
CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma 159
Reappraisal of Nodal Staging and Study of Lymph Node Station Involvement in Pancreaticoduodenectomy with the Standard International Study Group of Pancreatic Surgery Definition of Lymphadenectomy for Cancer 157
Over 700 Whipples for Pancreaticobiliary Malignancies: Postoperative Morbidity Is an Additional Negative Prognostic Factor for Distal Bile Duct Cancer 156
Reappraisal of nodal staging and study of lymph node station involvement in distal pancreatectomy for body-tail pancreatic ductal adenocarcinoma 153
Pancreatectomy with Para-Aortic Lymph Node Dissection for Pancreatic Head Adenocarcinoma: Pattern of Nodal Metastasis Spread and Analysis of Prognostic Factors 151
Verona Evidence-Based Meeting (EBM) 2020 on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: Meeting Report 147
ASO Visual Abstract: Ca 19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma 146
Solid pseudopapillary tumors of the pancreas: Specific pathological features predict the likelihood of postoperative recurrence 146
Serous cystic neoplasm of the pancreas: a multinational study of 2622 patients under the auspices of the International Association of Pancreatology and European Pancreatic Club (European Study Group on Cystic Tumors of the Pancreas) 145
Defining the practice of distal pancreatectomy around the world 145
The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms 142
The Sequential Radiographic Effects of Preoperative Chemotherapy and (Chemo)Radiation on Tumor Anatomy in Patients with Localized Pancreatic Cancer 142
Respect - A multicenter retrospective study on preoperative chemotherapy in locally advanced and borderline resectable pancreatic cancer 141
Defining the Safety Profile for Performing Pancreatoduodenectomy in the Setting of Hyperbilirubinemia 140
Identification of an Optimal Cut-off for Drain Fluid Amylase on Postoperative Day 1 for Predicting Clinically Relevant Fistula After Distal Pancreatectomy: A Multi-institutional Analysis and External Validation 137
Corrigendum: Body composition parameters, immunonutritional indexes, and surgical outcome of pancreatic cancer patients resected after neoadjuvant therapy: a retrospective, multicenter analysis 135
Guidelines on Pancreatic Cystic Neoplasms: Major Inconsistencies With Available Evidence and Clinical Practice- Results From an International Survey 134
Synchronous superior mesenteric-portal vein resection during pancreatectomy for T3 head adenocarcinoma: Perioperative outcomes and prognostic implications of histologically confirmed venous infiltration 134
Importance of Nodal Metastases Location in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: Results from a Prospective, Lymphadenectomy Protocol 134
Decision-Making for the Management of Cystic Lesions of the Pancreas: How Satisfied Are Patients with Surgery? 129
ASO Author Reflection: Location of Nodal Metastases in Pancreatoduodenectomy for Cancer: Which Station Matters? 127
Synchronous resections of hepatic oligometastatic pancreatic cancer: Disputing a principle in a time of safe pancreatic operations in a retrospective multicenter analysis 124
Pancreatogastrostomy Vs. Pancreatojejunostomy: a Risk-Stratified Analysis of 5316 Pancreatoduodenectomies 121
Evaluation of the MDACC clinical classification system for pancreatic cancer patients in an European multicenter cohort 120
Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy 117
ASO Visual Abstract: FOLFIRINOX or Gemcitabine Based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-Institutional, Patient-Level Meta-Analysis and Systematic Review 117
Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma 115
Number of Examined Lymph Nodes and Nodal Status Assessment in Distal Pancreatectomy for Body/Tail Ductal Adenocarcinoma 114
The Beneficial Effects of Minimizing Blood Loss in Pancreatoduodenectomy 112
Extended Experience with a Dynamic, Data-Driven Selective Drain Management Protocol in Pancreaticoduodenectomy: Progressive Risk Stratification for Better Practice 110
Evolving the Paradigm of Early Drain Removal Following Pancreatoduodenectomy 108
Identification of Patients for Adjuvant Therapy After Resection of Carcinoma of the Extrahepatic Bile Ducts: A Propensity Score-Matched Analysis 107
ASO Author Reflections: Recurrence Following Post-neoadjuvant Pancreatectomy: How Can We Do Better? 105
Reappraising the Concept of Conditional Survival After Pancreatectomy for Ductal Adenocarcinoma: A Bi-institutional Analysis 103
Revision of Pancreatic Neck Margins Based on Intraoperative Frozen Section Analysis Is Associated With Improved Survival in Patients Undergoing Pancreatectomy for Ductal Adenocarcinoma 101
The Influence of Intraoperative Blood Loss on Fistula Development Following Pancreatoduodenectomy 99
Surgical experience and the practice of pancreatoduodenectomy 98
Response to: Managing the High-risk Pancreatic Anastomosis 97
The Fistula Risk Score Catalog: Toward Precision Medicine for Pancreatic Fistula After Pancreatoduodenectomy 94
Intraductal Papillary Mucinous Neoplasm Around the World 94
Trends in practice patterns and outcomes: A decade of sarcoma care in the United States 94
Impact of Operative Time on Outcomes after Pancreatic Resection: A Risk-Adjusted Analysis Using the American College of Surgeons NSQIP Database 91
FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review 90
Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma 88
Pancreatic Head Resection Following Roux-en-Y Gastric Bypass: Operative Considerations and Outcomes 87
Response to Comment on "Reappraising the Concept of Conditional Survival After Pancreatectomy for Ductal Adenocarcinoma" 87
Pancreatic ductal adenocarcinoma: time for a neoadjuvant revolution? 85
Reappraisal of a 2-Cm Cut-Off Size for the Management of Cystic Pancreatic Neuroendocrine Neoplasms: A Multicenter International Study 78
Forecasting surgical costs: Towards informed financial consent and financial risk reduction 78
Response to: "Risk-adjusted Outcomes of Clinically Relevant Pancreatic Fistula Following Pancreatoduodenectomy: A Model for Performance Evaluation" 77
Taking Theory to Practice: Quality Improvement for Pancreaticoduodenectomy and Development and Integration of the Fistula Risk Score 76
Pasireotide for the Prevention of Postoperative Pancreatic Fistula: Time to Curb the Enthusiasm? 74
Outcomes of rescue procedures in the management of locally recurrent ampullary tumors: A Pancreas 2000/EPC study 68
Totale 11.376
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.436
article - articoli 40.964
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 969
patent - brevetti 0
selected - selezionate 0
volume - volumi 503
Totale 84.872
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022284 0 0 0 24 10 10 12 33 29 16 32 118
2022/20231.168 71 139 102 195 100 300 30 79 106 11 22 13
2023/2024639 26 64 64 65 67 115 54 42 14 18 79 31
2024/20251.623 81 90 54 251 79 34 98 114 229 118 146 329
2025/20264.990 365 218 343 742 1.304 321 447 278 386 307 87 192
2026/2027951 55 146 178 572 0 0 0 0 0 0 0 0
Totale 11.376